Oppenheimer & Co’s Select Medical SEM Stock Holding History

Oppenheimer & Co’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-21,817	Closed	-$184K	–	1483
2014 Q2	$184K	Buy	+21,817	New	+$169K	0.01%	1274

Other funds holding SEM

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Oppenheimer & Co's SEM Position: Q3 2014 in Review

Oppenheimer & Co sold out of Select Medical (SEM) in Q3 2014, closing a stake of 21,817 shares — an estimated $184K sold.

Oppenheimer & Co first reported a position in SEM in Q2 2014 and held it in 1 quarter. The position peaked at $184K in Q2 2014. 168 funds tracked by Wall St. Rank hold SEM as of Q3 2014.

Oppenheimer & Co reported no remaining Select Medical position as of Q3 2014 after selling out during the quarter.
Oppenheimer & Co sold 21,817 Select Medical shares in Q3 2014, an estimated $184K.
Oppenheimer & Co first reported a position in Select Medical in Q2 2014 and held it in 1 quarter.
Oppenheimer & Co's Select Medical position peaked at $184K in Q2 2014.
168 funds tracked by Wall St. Rank held Select Medical as of Q3 2014.

Based on Oppenheimer & Co's 13F filing for Q3 2014, filed 12 Nov 2014.